July/August 2016

Varying strategies among managed care organizations for PCSK9 inhibitors will shape the care of high-risk cardiovascular patients.

Pharmacy set-up, packaging selections, and patient management technologies are vital in the proper handling and administration of cold chain drug products.

Pharmacies may be able to achieve significant savings and operational efficiencies with the cloud.

Large integrated delivery networks and academic medical centers with specialty clinics and infrastructure should consider building in-house specialty pharmacy capability.

Electronic prior authorization may enhance support for a value-based pharmaceutical market.

Payers, providers, manufacturers, and patients will need to navigate a complicated landscape in the shift to value-based health care.

New biologic agents have altered the treatment of IBD, but understanding among specialty pharmacists of extraintestinal manifestations is often unclear.

Closed system transfer devices protect health care professionals compounding and administering hazardous drugs.

Changes in reimbursement or in how specialty drugs are prescribed will impact the bottom line of specialty pharmacies.

Medication adherence is a complex issue that demands a herculean effort by the specialty pharmacy.

The Baby Boomer generation will stretch the resources of the US health care system, with technology-driven behaviors that force a reevaluation of the delivery of care.

New therapies on the horizon for cancer, multiple sclerosis, and rheumatoid arthritis.

Specialty pharmacies need to determine their role with both existing and emerging therapies in the chain of value-based care.